Profil bibliographique

Myrtani Pieri

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

41Publications signalées

874Citations signalées

1Affiliations récentes

Institutions déclarées

Domaines associés

SARS-CoV-2 and COVID-19 ResearchCell Adhesion Molecules ResearchRenal Diseases and GlomerulopathiesMicroRNA in disease regulationCOVID-19 Clinical Research Studies

Publications récentes

Accès ouvert 2026 articleOpenAlex

Integrating Circulating miRNA Profiles, Glycosylation, and Volatile Organic Compound Signatures Toward Multimodal Liquid Biopsy for Early Detection of Ovarian Cancer: A Molecular Framework

Myrtani Pieri, Siobhan Brushett, Ioannis Gallos, Sofia Fragoso et autres

0 citationsApplied Sciences

Accès ouvert 2025 reviewOpenAlex

The Effect of Intradialytic Exercise on Cognition in Renal Patients Undergoing Hemodialysis: An Updated Systematic Review of Randomized Controlled Trials

Nicos Mitsides, Myrtani Pieri, Eleni Andreou, Giorgos K. Sakkas et autres

1 citationHealthcare

Accès ouvert 2025 articleOpenAlex

Chemical chaperone 4-phenylbutyrate treatment alleviates the kidney phenotype in a mouse model of Alport syndrome with a pathogenic variant in Col4a3

Pavlos Ioannou, Christoforos Odiatis, Rania Hadjisavva, Kyriaki I. Antoniadou et autres

5 citationsKidney International

2024 articleOpenAlex

Evaluating the evening carbohydrate dilemma: the effect of within-the-day carbohydrate periodization on body composition and physical fitness

Angelos Vlahoyiannis, Eleni Andreou, George Aphamis, Kyriacos Felekkis et autres

1 citationEuropean Journal of Nutrition

Accès ouvert 2024 reviewOpenAlex

Exploring the Dynamic Relationship between the Gut Microbiome and Body Composition across the Human Lifespan: A Systematic Review

Ifigeneia Komodromou, Eleni Andreou, Angelos Vlahoyiannis, Maria Christofidou et autres

29 citationsNutrients

Accès ouvert 2023 articleOpenAlex

Exploring the Feasibility of Circulating miRNAs as Diagnostic and Prognostic Biomarkers in Osteoarthritis: Challenges and Opportunities

Kyriacos Felekkis, Myrtani Pieri, Christos Papaneophytou

23 citationsInternational Journal of Molecular Sciences

Accès ouvert 2023 articleOpenAlex

#5441 EVIDENCE THAT CHAPERONE 4-PBA TREATMENT ALLEVIATES THE RENAL PHENOTYPE IN ALPORT SYNDROME MOUSE MODELS

Pavlos Ioannou, Christoforos Odiatis, Kyriaki I. Antoniadou, Myrtani Pieri et autres

0 citationsNephrology Dialysis Transplantation

Accès ouvert 2023 articleOpenAlex

Special Issue: The Impact of Early Life Nutrition on Gut Maturation and Later Life Gut Health

Myrtani Pieri, Vicky Nicolaidou, Christos Papaneophytou

7 citationsNutrients

Accès ouvert 2023 reviewOpenAlex

Detection of SARS-CoV-2–Specific Antibodies in Human Breast Milk and Their Neutralizing Capacity after COVID-19 Vaccination: A Systematic Review

Vicky Nicolaidou, Rafaela Georgiou, Maria Christofidou, Kyriacos Felekkis et autres

16 citationsInternational Journal of Molecular Sciences

Accès ouvert 2023 articleOpenAlex

Alterations in Circulating miRNA Levels after Infection with SARS-CoV-2 Could Contribute to the Development of Cardiovascular Diseases: What We Know So Far

Myrtani Pieri, Panayiotis Vayianos, Vicky Nicolaidou, Kyriacos Felekkis et autres

19 citationsInternational Journal of Molecular Sciences

Accès ouvert 2022 reviewOpenAlex

Biodiversity: the overlooked source of human health

Yuliya Linhares, Alexander Kaganski, Christian Agyare, Işıl Aksan Kurnaz et autres

45 citationsTrends in Molecular Medicine

Accès ouvert 2022 articleOpenAlex

Survival of Vaccine-Induced Human Milk SARS-CoV-2 IgG, IgA and SIgA Immunoglobulins across Simulated Human Infant Gastrointestinal Digestion

Myrtani Pieri, Maria‐Arsenia Maniori, Lucy Shahabian, Elie Kanaan et autres

21 citationsNutrients

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.